Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Mol Med. 2002 Jan;8(1):44-7.

Telomere shortening and cell fates in mouse models of neoplasia.

Author information

1
Dept of Hematology, Cancer Biology Program, Stanford University School of Medicine, Stanford, CA 94304, USA. sartandi@stanford.edu

Abstract

Cell division in the absence of telomerase leads to telomere shortening that can activate checkpoint responses and impair chromosomal stability. The absence of telomerase in primary human cells and its near universal reactivation in human cancers has highlighted the importance of telomere shortening and telomerase reactivation during tumor development. Data from telomerase-deficient mouse models of cancer have indicated that telomere shortening can exert profoundly different influences on cell fates in developing cancers, limiting tumorigenesis by enhancing cell death or facilitating carcinogenesis by compromising chromosomal stability. These alternate fates depend on the integrity of the p53 pathway and on cell type.

PMID:
11796266
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center